Nu Skin Enterprises (NYSE:NUS) Posts Earnings Results, Misses Estimates By $0.01 EPS

Nu Skin Enterprises (NYSE:NUS) announced its quarterly earnings results on Thursday. The company reported $0.29 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.01), FiscalAI reports. The firm had revenue of $370.32 million during the quarter, compared to analysts’ expectations of $382.70 million. Nu Skin Enterprises had a net margin of 10.79% and a return on equity of 8.21%. Nu Skin Enterprises updated its FY 2026 guidance to 0.800-1.200 EPS and its Q1 2026 guidance to 0.100-0.200 EPS.

Here are the key takeaways from Nu Skin Enterprises’ conference call:

• Prysm iO is the centerpiece of Nu Skin’s transformation — a non‑invasive carotenoid scanner powered by a 21M‑scan database and AI that the company plans to place >100,000 devices in 2026 and monetize via subscriptions with materially higher customer lifetime value.
• 2025 results showed meaningful improvement: adjusted EPS of $1.27 (up ~51% YoY), gross‑margin expansion, stronger liquidity (~$240M cash, reduced debt) and shareholder returns via dividends and $20M repurchases.
• 2026 guidance is cautious — revenue guidance of $1.35B–$1.5B and EPS of $0.80–$1.20 (assumes a ~35% tax rate) with growth expected mainly in the back half, leaving near‑term top‑line pressure and a seasonally weak Q1.
• India pre‑market operations began in Nov 2025 with a formal launch targeted for late 2026; management views India as a major long‑term opportunity but notes local infrastructure, import duties, and longer sales cycles that will limit near‑term contribution.

Nu Skin Enterprises Trading Down 18.0%

NUS stock opened at $8.37 on Friday. The company has a current ratio of 2.15, a quick ratio of 1.45 and a debt-to-equity ratio of 0.26. The business’s 50-day moving average is $10.34 and its 200 day moving average is $10.65. The stock has a market cap of $408.09 million, a price-to-earnings ratio of 2.62 and a beta of 1.01. Nu Skin Enterprises has a 12-month low of $5.32 and a 12-month high of $14.62.

Nu Skin Enterprises Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 11th. Investors of record on Friday, February 27th will be paid a $0.06 dividend. The ex-dividend date of this dividend is Friday, February 27th. This represents a $0.24 dividend on an annualized basis and a yield of 2.9%. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 7.50%.

Key Headlines Impacting Nu Skin Enterprises

Here are the key news stories impacting Nu Skin Enterprises this week:

• Positive Sentiment: Board declared a quarterly cash dividend of $0.06 per share (yield ~2.3%), payable Mar. 11 to holders of record Feb. 27 — supports income investors and signals capital-return discipline. Dividend Announcement
• Positive Sentiment: Management is pushing a strategic transformation (including India expansion) and commercial rollout of the Prysm iO device, targeting placement of 100,000 units in 2026 — a potential long-term revenue driver if adoption accelerates. Prysm iO / Strategy Article
• Neutral Sentiment: Company states Q4 and full-year results were within its guidance framework and highlighted >50% growth in 2025 earnings (adjusted), but the positive messaging contrasts with misses vs. external consensus — investors should weigh management framing against external estimates. Business Wire Release
• Neutral Sentiment: Coverage update from Stonegate reiterates reported Q4 numbers (revenue $370.3M; adjusted NI $14.5M; adj EPS $0.29) — a restatement of results rather than a new catalyst. Stonegate Coverage Update
• Negative Sentiment: Q4 results missed consensus: EPS $0.29 vs. $0.30 expected; revenue $370.3M vs. $382.7M expected — revenues fell 16.9% year-over-year with broad declines across key regions, which pressures near-term top-line recovery. Zacks Earnings Miss
• Negative Sentiment: Management cut Q1 and FY2026 guidance meaningfully below consensus — Q1 EPS $0.10–0.20 (street ~$0.29) and FY EPS $0.80–1.20 (street ~$1.42); revenue ranges likewise sit below expectations — the guidance shortfall is the primary driver of the market reaction. Guidance & Press Release
• Negative Sentiment: Analyst and media transcripts reiterate the miss and highlight deteriorating customer counts (paid affiliates down ~10%) and margin pressures; near-term fundamentals appear weaker than the market had modeled. Earnings Call Transcript

Institutional Investors Weigh In On Nu Skin Enterprises

A number of large investors have recently made changes to their positions in NUS. Wexford Capital LP purchased a new stake in shares of Nu Skin Enterprises in the third quarter valued at about $40,000. Tower Research Capital LLC TRC raised its stake in shares of Nu Skin Enterprises by 107.4% in the second quarter. Tower Research Capital LLC TRC now owns 5,048 shares of the company’s stock valued at $40,000 after acquiring an additional 2,614 shares in the last quarter. Banque Cantonale Vaudoise acquired a new stake in Nu Skin Enterprises in the 3rd quarter valued at about $57,000. Quadrant Capital Group LLC purchased a new position in Nu Skin Enterprises in the third quarter worth approximately $85,000. Finally, National Bank of Canada FI grew its stake in shares of Nu Skin Enterprises by 1,040,200.0% during the third quarter. National Bank of Canada FI now owns 10,403 shares of the company’s stock worth $127,000 after purchasing an additional 10,402 shares in the last quarter. 82.84% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Zacks Research upgraded Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a report on Friday, January 30th. Weiss Ratings reissued a “hold (c)” rating on shares of Nu Skin Enterprises in a report on Thursday, January 22nd. Finally, Wall Street Zen lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Saturday. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, Nu Skin Enterprises currently has a consensus rating of “Hold”.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.